Zobrazeno 71 - 80
of 151
pro vyhledávání: '"Onno W. Akkerman"'
Autor:
van der Tjipke Werf, J A Dijkstra, Jos G. W. Kosterink, Onno W. Akkerman, R. van Altena, Johannes H. Proost, de Wiel Lange, Jan-Willem C. Alffenaar
Publikováno v:
International journal of antimicrobial agents, 46(3), 332-337. Elsevier Bedrijfsinformatie b.v.
International Journal of Antimicrobial Agents, 46(3), 332-7. Elsevier
Dijkstra, J A, van Altena, R, Akkerman, O W, de Lange, W C M, Proost, J H, van der Werf, T S, Kosterink, J G W & Alffenaar, J W C 2015, ' Limited sampling strategies for therapeutic drug monitoring of amikacin and kanamycin in patients with multidrug-resistant tuberculosis ', International Journal of Antimicrobial Agents, vol. 46, no. 3, pp. 332-7 . https://doi.org/10.1016/j.ijantimicag.2015.06.008
International Journal of Antimicrobial Agents, 46(3), 332-7. Elsevier
Dijkstra, J A, van Altena, R, Akkerman, O W, de Lange, W C M, Proost, J H, van der Werf, T S, Kosterink, J G W & Alffenaar, J W C 2015, ' Limited sampling strategies for therapeutic drug monitoring of amikacin and kanamycin in patients with multidrug-resistant tuberculosis ', International Journal of Antimicrobial Agents, vol. 46, no. 3, pp. 332-7 . https://doi.org/10.1016/j.ijantimicag.2015.06.008
Amikacin and kanamycin are considered important and effective drugs in the treatment of multidrug-resistant tuberculosis (MDR-TB). Unfortunately, the incidence of toxicity is high and is related to elevated drug exposure. In order to achieve a balanc
Autor:
Macky M. Done, Riejanne Stienstra, Tjip S. van der Werf, Wiel C M de Lange, Wud Al-Kailany, Onno W. Akkerman, Gonda J. de Jonge, Johanneke Kleinnijenhuis
Publikováno v:
Infection
Infection, 48. Urban und Vogel GmbH
Infection, 48. Urban und Vogel GmbH
Background Paradoxical reaction after the initiation of tuberculosis treatment is defined as increased inflammation following effective antimycobacterial treatment. This is a phenomenon that can severely complicate a patient’s recovery, potentially
Autor:
Tony Eger, Adri G. M. van der Zanden, Frank Rietkerk, Onno W. Akkerman, Tjip S. van der Werf, Dick van Soolingen, Kees van der Loo
Publikováno v:
Medical Microbiology and Immunology. 209:705-705
An animal keeper was diagnosed with pulmonary tuberculosis (TB) after bi-annual screening for latent TB infection in zoo employees. In the same period, several bonobos of the zoo were suffering from TB as well. The Mycobacterium tuberculosis strains
Autor:
Onno W. Akkerman, Jan-Willem C. Alffenaar, Fajri Gafar, Natasha van't Boveneind-Vrubleuskaya, Taichi Ochi, Bob Wilffert, Susan van den Hof, Tjip S. van der Werf, Connie Erkens
Publikováno v:
European Respiratory Journal, 56(4):2001086. EUROPEAN RESPIRATORY SOC JOURNALS LTD
BackgroundTuberculosis (TB) in children and adolescents is a sentinel event for ongoing transmission. In the Netherlands, epidemiological characteristics of childhood and adolescent TB have not been fully evaluated. Therefore, we aimed to assess TB e
Autor:
Onno W. Akkerman, Mina Yousofi, Bart L. Rottier, Hester van der Vaart, Henderik W. Frijlink, Daan J Touw, Johannes G. M. Burgerhof, A M Akkerman-Nijland, Gerard H. Koppelman
Publikováno v:
Therapeutic advances in respiratory disease, 14:1753466620905279. SAGE Publications Inc.
Background: Pseudomonas aeruginosa ( Pa) is the predominant pulmonary pathogen in patients with cystic fibrosis (CF). Tobramycin nebulization is used for the eradication of Pa infection. Nowadays, tobramycin dry powder inhalation (DPI) is available a
Autor:
Martin J. Boeree, Cecile Magis-Escurra, Tjip S. van der Werf, Gerard de Vries, Wouter Hoefsloot, Wiel C M de Lange, Huib A. M. Kerstjens, Dick van Soolingen, Richard van Altena, Mathieu S. Bolhuis, Onno W. Akkerman, Jan-Willem C. Alffenaar
Publikováno v:
European Respiratory Journal, 48(6), 1800-1802. EUROPEAN RESPIRATORY SOC JOURNALS LTD
European Respiratory Journal, 48, 1800-2
European Respiratory Journal, 48, 6, pp. 1800-2
European Respiratory Journal, 48, 1800-2
European Respiratory Journal, 48, 6, pp. 1800-2
We welcome the initiative by the Guideline Development Group (GDG) members to issue the 2016 update of World Health Organization (WHO) treatment guidelines for drug-resistant tuberculosis (TB) [1]. With one in two patients currently failing on treatm
Autor:
Sander P, van Rijn, Marlanka A, Zuur, Richard, Anthony, Bob, Wilffert, Richard, van Altena, Onno W, Akkerman, Wiel C M, de Lange, Tjip S, van der Werf, Jos G W, Kosterink, Jan-Willem C, Alffenaar
Publikováno v:
Antimicrobial agents and chemotherapy. 63(2)
Multi- and extensively drug-resistant tuberculosis (M/XDR-TB) has become an increasing threat not only in countries where the TB burden is high but also in affluent regions, due to increased international travel and globalization. Carbapenems are ear
Autor:
José-María García-García, Jerker Jonsson, Fabrizio Palmieri, Luigi Codecasa, Matteo Zignol, Andrei Maryandyshev, Qingshan Cai, Domingo Palmero, Magnolia Nieto Marcos, Seifeldin Eltaeb Elamin, Enrique Bernal, Simon Tiberi, Alberto Matteelli, Marisa Vescovo, Judith Bruchfeld, Edita Davidavičienė, Saulius Diktanas, Skaidrius Miliauskas, Rolandas Zablockis, Raquel Duarte, R. Rosso, Martin J. Boeree, Marcela Muñoz-Torrico, Valentina Marchese, Adrian Rendon, Evgeny Belilovski, Sergey Borisov, Zarir F Udwadia, Antoniya Koleva, Jorge De Los Rios, Giovanni Battista Migliori, Ana Garcia, Elena Martínez Robles, Hamdan Mustafa Hamdan, Vygantas Gruslys, Marina Tadolini, Laurent P. Nicod, Laura Saderi, Alena Aleksa, Mahamadou Bassirou Souleymane, Rafael Laniado-Laborín, Vinicio Manfrin, Jesica Mazza-Stalder, Alberto Piubello, Charalampos Moschos, Liga Kuksa, Alexey Filippov, Giovanni Sotgiu, Lia D'Ambrosio, Agostina Pontarelli, Heinke Kunst, Pietro Viggiani, Jan-Willem C. Alffenaar, Emanuele Pontali, Maurizio Ferrarese, Regina Gayoso, Ieva Gaudiesiute, Onno W. Akkerman, Agnese Šmite, Edvardas Danila, Marie-Christine Payen, Justin T Denholm, Jacinta Drakšienė, Blagovesta Gavazova, Wouter Hoefsloot, Elena Khimova, Dina Visca, Askar Yedilbayev, Nadia Escobar Salinas, Julen Cadiñanos Loidi, Sarai Quirós, Ivan Solovic, Jose A. Caminero, Margareth Pretti Dalcolmo, Apostolos Papavasileiou, Gina Gualano, Birutė Nakčerienė, Martin van den Boom, Lina Davies Forsman, Dmitry Zhurkin, Yang Li, Alena Skrahina, Antonio Spanevello, Cecile Magis-Escurra, Masoud Dara, Selene Manga, Jose Joaquin Cebrian Gallardo, Rosella Centis
Publikováno v:
European Respiratory Journal, 54, 6
European Respiratory Journal, 54(6):1901522. EUROPEAN RESPIRATORY SOC JOURNALS LTD
European Respiratory Journal, 54
European Respiratory Journal, 54(6):1901522. EUROPEAN RESPIRATORY SOC JOURNALS LTD
European Respiratory Journal, 54
The World Health Organization (WHO) recommends that countries implement pharmacovigilance and collect information on active drug safety monitoring (aDSM) and management of adverse events.The aim of this prospective study was to evaluate the frequency
Autor:
Onno W. Akkerman, Marlanka A Zuur, T S van der Werf, W C M de Lange, Samiksha Ghimire, Mathieu S. Bolhuis, Daan J Touw, R. van Altena, Jos G. W. Kosterink, A. M. A. Wessels, Jan-Willem C. Alffenaar
Publikováno v:
Antimicrobial Agents and Chemotherapy, 62(5):02250. AMER SOC MICROBIOLOGY
Ertapenem is a carbapenem antibiotic with activity against Mycobacterium tuberculosis . Dose simulations in a hollow-fiber infection model showed that 2,000 mg once daily is an appropriate dose to be tested in clinical studies. Before using this dose
Autor:
Melinda Munang, Rafael Mello Galliez, Viet Nhung Nguyen, Jung-Yien Chien, Takashi Yoshiyama, Dick Menzies, Anthony J. Garcia-Prats, Won-Jung Koh, Peter Cegielski, Afranio Lineu Kritski, Onno W. Akkerman, Payam Tabarsi, Patrick P. J. Phillips, Mayara Lisboa Bastos, Piret Viiklepp, Parvaneh Baghaei, James C. Johnston, Andrea Benedetti, Stephen H. Gillespie, Medea Gegia, Judith R. Glynn, Martin Dedicoat, Corinne Merle, Randall Reves, Kwonjune J. Seung, Jong Sun Park, Edward C. Jones-López, Alena Skrahina, Awal Khan, Connie Erkens, Ethel Leonor Noia Maciel, Kamila Romanowski, Jann-Yuan Wang, Dick van Soolingen, Shama D. Ahuja, Stefan V. Goldberg, C Ponnuraja, Patricio Escalante, Velayutham V. Banurekha, Helen Cox, Anete Trajman, Jae Ho Lee, Akihiro Ohkado, Federica Fregonese, David E. Griffith, Pei Zhi Li, Dennis Falzon, Irene Ayakaka, Lisa Trieu, Zhi Yi Lan, Didi Bang, G. Narendran, H. Simon Schaaf, Denise Arakaki-Sanchez, Karen R. Jacobson, Adithya Cattamanchi, Andrew J. Nunn, Maryline Bonnet
Publikováno v:
The Lancet. Respiratory medicine, vol 6, iss 4
Lancet Respir Med
The Lancet. Respiratory Medicine, 6(4), 265-275. ELSEVIER SCI LTD
Lancet Respir Med
The Lancet. Respiratory Medicine, 6(4), 265-275. ELSEVIER SCI LTD
Funding: World Health Organization and Canadian Institutes of Health Research. Background: Isoniazid-resistant, rifampicin-susceptible (INH-R) tuberculosis is the most common form of drug resistance, and is associated with failure, relapse, and acqui
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7967236d9bab4d4661bdc688ed1b4539
https://escholarship.org/uc/item/8658c7xr
https://escholarship.org/uc/item/8658c7xr